Abstract
Radiofrequency ablation (RFA) has gained steadily increasing interest as an alternative to surgery. Previous reports on primary nonsmall-cell lung cancer (NSCLC) have shown a local control rate after RFA varying between 58% and 68% (median follow-up between 17 and 28 months), with an overall 3-year survival rate of 47%. Pneumothorax represents the main complication of RFA, occurring in 17% to 68% of procedures. We report a case of a wedge resection performed 4 weeks after RFA containing 40% viable adenocarcinoma cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Thoracic and Cardiovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
